

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular epithelial cell development (GO:0072310) | 9.01252404 |
| 2 | glomerular basement membrane development (GO:0032836) | 8.51915792 |
| 3 | glomerulus development (GO:0032835) | 5.04783490 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.02661435 |
| 5 | drug transmembrane transport (GO:0006855) | 4.32898089 |
| 6 | excretion (GO:0007588) | 4.07700991 |
| 7 | positive regulation of fibroblast migration (GO:0010763) | 4.05631089 |
| 8 | lysine catabolic process (GO:0006554) | 4.00541045 |
| 9 | lysine metabolic process (GO:0006553) | 4.00541045 |
| 10 | blood vessel maturation (GO:0001955) | 4.00229027 |
| 11 | urate metabolic process (GO:0046415) | 3.93949608 |
| 12 | kidney mesenchyme development (GO:0072074) | 3.72454140 |
| 13 | positive regulation of p38MAPK cascade (GO:1900745) | 3.70501458 |
| 14 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.65519897 |
| 15 | surfactant homeostasis (GO:0043129) | 3.53758846 |
| 16 | metanephric mesenchyme development (GO:0072075) | 3.49029574 |
| 17 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.44203815 |
| 18 | metanephric epithelium development (GO:0072207) | 3.43574107 |
| 19 | drug transport (GO:0015893) | 3.39854395 |
| 20 | organic cation transport (GO:0015695) | 3.26997983 |
| 21 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.24313544 |
| 22 | keratan sulfate catabolic process (GO:0042340) | 3.22033364 |
| 23 | phosphate ion transport (GO:0006817) | 3.19552617 |
| 24 | cellular response to vitamin D (GO:0071305) | 3.17636219 |
| 25 | metanephric nephron tubule development (GO:0072234) | 3.16220701 |
| 26 | metanephric tubule development (GO:0072170) | 3.16220701 |
| 27 | renal absorption (GO:0070293) | 3.13976698 |
| 28 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.12247256 |
| 29 | tricarboxylic acid metabolic process (GO:0072350) | 3.12194881 |
| 30 | valine metabolic process (GO:0006573) | 3.03437231 |
| 31 | quaternary ammonium group transport (GO:0015697) | 3.02862564 |
| 32 | cell adhesion mediated by integrin (GO:0033627) | 3.02838689 |
| 33 | cellular response to vitamin (GO:0071295) | 2.99658685 |
| 34 | lung vasculature development (GO:0060426) | 2.99472562 |
| 35 | metanephric nephron epithelium development (GO:0072243) | 2.97244183 |
| 36 | extracellular fibril organization (GO:0043206) | 2.95447315 |
| 37 | positive regulation of muscle hypertrophy (GO:0014742) | 2.88497082 |
| 38 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.88497082 |
| 39 | response to mercury ion (GO:0046689) | 2.85467960 |
| 40 | branched-chain amino acid metabolic process (GO:0009081) | 2.82217929 |
| 41 | toxin transport (GO:1901998) | 2.81458157 |
| 42 | substrate-dependent cell migration (GO:0006929) | 2.80623372 |
| 43 | cell migration involved in heart development (GO:0060973) | 2.77777958 |
| 44 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.75888658 |
| 45 | regulation of p38MAPK cascade (GO:1900744) | 2.75480573 |
| 46 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74427803 |
| 47 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.74320693 |
| 48 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.74166146 |
| 49 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.74112271 |
| 50 | regulation of muscle hypertrophy (GO:0014743) | 2.73444296 |
| 51 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.73400721 |
| 52 | venous blood vessel morphogenesis (GO:0048845) | 2.72425502 |
| 53 | chemical homeostasis within a tissue (GO:0048875) | 2.72381462 |
| 54 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.68646797 |
| 55 | Golgi transport vesicle coating (GO:0048200) | 2.68005225 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 2.68005225 |
| 57 | homocysteine metabolic process (GO:0050667) | 2.67772456 |
| 58 | apoptotic cell clearance (GO:0043277) | 2.67484595 |
| 59 | renal filtration (GO:0097205) | 2.65694641 |
| 60 | fibril organization (GO:0097435) | 2.64587539 |
| 61 | cellular response to ethanol (GO:0071361) | 2.63583542 |
| 62 | macroautophagy (GO:0016236) | 2.62395495 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 2.61772003 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 2.61476364 |
| 65 | nephron epithelium morphogenesis (GO:0072088) | 2.59904279 |
| 66 | nephron tubule morphogenesis (GO:0072078) | 2.59904279 |
| 67 | renal tubule morphogenesis (GO:0061333) | 2.59794803 |
| 68 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.58054004 |
| 69 | nephron tubule development (GO:0072080) | 2.57485071 |
| 70 | carnitine transport (GO:0015879) | 2.56720020 |
| 71 | amino-acid betaine transport (GO:0015838) | 2.56720020 |
| 72 | * wound healing, spreading of epidermal cells (GO:0035313) | 2.56680262 |
| 73 | membrane raft organization (GO:0031579) | 2.55987972 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55182924 |
| 75 | positive regulation of receptor recycling (GO:0001921) | 2.54048214 |
| 76 | coronary vasculature morphogenesis (GO:0060977) | 2.53990538 |
| 77 | smooth muscle tissue development (GO:0048745) | 2.53100932 |
| 78 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.53022347 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 2.52010658 |
| 80 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.51587087 |
| 81 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.51228677 |
| 82 | chondrocyte proliferation (GO:0035988) | 2.49961377 |
| 83 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49581471 |
| 84 | glycoside metabolic process (GO:0016137) | 2.49521843 |
| 85 | regulation of axon guidance (GO:1902667) | 2.48411465 |
| 86 | actin filament depolymerization (GO:0030042) | 2.48062723 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 2.48033590 |
| 88 | drug catabolic process (GO:0042737) | 2.47022097 |
| 89 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.46753440 |
| 90 | negative regulation of fatty acid transport (GO:2000192) | 2.45968185 |
| 91 | renal tubule development (GO:0061326) | 2.43789856 |
| 92 | peptide catabolic process (GO:0043171) | 2.42443116 |
| 93 | regulation of fibroblast migration (GO:0010762) | 2.41799089 |
| 94 | nephron epithelium development (GO:0072009) | 2.41404260 |
| 95 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.39794242 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38886258 |
| 97 | endodermal cell differentiation (GO:0035987) | 2.38404971 |
| 98 | glyoxylate metabolic process (GO:0046487) | 2.38185404 |
| 99 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.38175225 |
| 100 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.37863802 |
| 101 | pericardium development (GO:0060039) | 2.37128343 |
| 102 | branched-chain amino acid catabolic process (GO:0009083) | 2.37011689 |
| 103 | sprouting angiogenesis (GO:0002040) | 2.36617802 |
| 104 | positive regulation of macrophage cytokine production (GO:0060907) | 2.36300917 |
| 105 | exogenous drug catabolic process (GO:0042738) | 2.34730473 |
| 106 | protein localization to endosome (GO:0036010) | 2.34500021 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 2.33520204 |
| 108 | exocrine pancreas development (GO:0031017) | 2.33295416 |
| 109 | lymphangiogenesis (GO:0001946) | 2.33198440 |
| 110 | fatty acid oxidation (GO:0019395) | 2.33114362 |
| 111 | regulation of macrophage cytokine production (GO:0010935) | 2.31301467 |
| 112 | protein heterotrimerization (GO:0070208) | 2.30534479 |
| 113 | lipid oxidation (GO:0034440) | 2.30478129 |
| 114 | endothelium development (GO:0003158) | 2.29927266 |
| 115 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29435168 |
| 116 | cellular response to epinephrine stimulus (GO:0071872) | 2.29026248 |
| 117 | negative regulation of axon guidance (GO:1902668) | 2.28835174 |
| 118 | endothelial cell chemotaxis (GO:0035767) | 2.28791212 |
| 119 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.28191069 |
| 120 | phosphate ion transmembrane transport (GO:0035435) | 2.28050401 |
| 121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.27929982 |
| 122 | axon extension involved in axon guidance (GO:0048846) | 2.27657860 |
| 123 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.27657860 |
| 124 | cell differentiation involved in kidney development (GO:0061005) | 2.27407115 |
| 125 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.27284517 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.26818510 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.26447959 |
| 128 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.25477029 |
| 129 | detection of molecule of bacterial origin (GO:0032490) | 2.25135025 |
| 130 | 2-oxoglutarate metabolic process (GO:0006103) | 2.25074182 |
| 131 | negative regulation of protein autophosphorylation (GO:0031953) | 2.24127127 |
| 132 | negative regulation of monooxygenase activity (GO:0032769) | 2.23594024 |
| 133 | negative regulation of anoikis (GO:2000811) | 2.21910550 |
| 134 | peptide hormone processing (GO:0016486) | 2.21814415 |
| 135 | negative regulation of metanephros development (GO:0072217) | 2.21638705 |
| 136 | trivalent inorganic anion homeostasis (GO:0072506) | 2.21496670 |
| 137 | phosphate ion homeostasis (GO:0055062) | 2.21496670 |
| 138 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.21342379 |
| 139 | collagen fibril organization (GO:0030199) | 2.21250118 |
| 140 | diaphragm development (GO:0060539) | 2.21049905 |
| 141 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.19949226 |
| 142 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.19740703 |
| 143 | positive regulation of glycolytic process (GO:0045821) | 2.18333426 |
| 144 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.18255112 |
| 145 | polyol transport (GO:0015791) | 2.17228679 |
| 146 | histamine secretion (GO:0001821) | 2.17048878 |
| 147 | artery development (GO:0060840) | 2.16716506 |
| 148 | regulation of alkaline phosphatase activity (GO:0010692) | 2.16027284 |
| 149 | energy homeostasis (GO:0097009) | 2.15455509 |
| 150 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.14842919 |
| 151 | regulation of muscle adaptation (GO:0043502) | 2.14502788 |
| 152 | type B pancreatic cell proliferation (GO:0044342) | 2.13274296 |
| 153 | glomerular filtration (GO:0003094) | 2.13249377 |
| 154 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.12944687 |
| 155 | skin morphogenesis (GO:0043589) | 2.12656646 |
| 156 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11521947 |
| 157 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.11364288 |
| 158 | collagen metabolic process (GO:0032963) | 2.10737667 |
| 159 | angiotensin maturation (GO:0002003) | 2.10482133 |
| 160 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.10004802 |
| 161 | endocrine hormone secretion (GO:0060986) | 2.09081257 |
| 162 | positive regulation of catenin import into nucleus (GO:0035413) | 2.08982445 |
| 163 | extracellular matrix assembly (GO:0085029) | 2.07761074 |
| 164 | inositol phosphate-mediated signaling (GO:0048016) | 2.05082445 |
| 165 | collagen catabolic process (GO:0030574) | 2.04302709 |
| 166 | chondrocyte development (GO:0002063) | 2.03812672 |
| 167 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.03664021 |
| 168 | regulation of sarcomere organization (GO:0060297) | 2.02443916 |
| 169 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.02393653 |
| 170 | response to epinephrine (GO:0071871) | 2.02103258 |
| 171 | gland morphogenesis (GO:0022612) | 2.01963967 |
| 172 | negative regulation of adherens junction organization (GO:1903392) | 2.01040516 |
| 173 | negative regulation of focal adhesion assembly (GO:0051895) | 2.01040516 |
| 174 | negative regulation of cell junction assembly (GO:1901889) | 2.01040516 |
| 175 | positive regulation of actin filament depolymerization (GO:0030836) | 2.01001173 |
| 176 | glomerular visceral epithelial cell development (GO:0072015) | 10.1593453 |
| 177 | positive regulation of endothelial cell migration (GO:0010595) | 1.98885283 |
| 178 | barbed-end actin filament capping (GO:0051016) | 1.98386472 |
| 179 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.97555947 |
| 180 | regulation of cardiac muscle cell differentiation (GO:2000725) | 1.95555520 |
| 181 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.94334883 |
| 182 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.94334883 |
| 183 | macrophage activation (GO:0042116) | 1.94282444 |
| 184 | dermatan sulfate biosynthetic process (GO:0030208) | 1.93844664 |
| 185 | response to magnesium ion (GO:0032026) | 1.93641802 |
| 186 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.93565055 |
| 187 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 1.93230720 |
| 188 | response to gravity (GO:0009629) | 1.93006783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.31876887 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02335454 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.49355105 |
| 4 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.19412519 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16168951 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13722939 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10936314 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04410792 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04165675 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01663165 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95830108 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88540115 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82722687 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79334651 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74799107 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73099851 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69591058 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67618232 |
| 19 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67541131 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64648278 |
| 21 | TP53_16413492_ChIP-PET_HCT116_Human | 1.64215943 |
| 22 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59156321 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55647813 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55382787 |
| 25 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54662854 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52067866 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.51962051 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.48960410 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46625146 |
| 30 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.44095807 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40583159 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38543823 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38319047 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37729534 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37546707 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37485605 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36359211 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36359211 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35989073 |
| 40 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34780237 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34777625 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32979141 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32979141 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31651614 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29981359 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29027117 |
| 47 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28593540 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27273611 |
| 49 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27049987 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27006029 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26420140 |
| 52 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26286298 |
| 53 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25461017 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23993039 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23190508 |
| 56 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22525167 |
| 57 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21191639 |
| 58 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21186699 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20600301 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18963254 |
| 61 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18159018 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17167465 |
| 63 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17024358 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16705945 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16258699 |
| 66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15668928 |
| 67 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15668928 |
| 68 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15144943 |
| 69 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14743966 |
| 70 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14078692 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14000820 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13091281 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12221152 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12171201 |
| 75 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11514025 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10233554 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08324726 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07276722 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06952922 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05950140 |
| 81 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05728760 |
| 82 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05620511 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03594286 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03215607 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03083196 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02863431 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02636273 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01328515 |
| 89 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.01131091 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99613742 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99513199 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99214150 |
| 93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98875060 |
| 94 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98831098 |
| 95 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98492586 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97899389 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97765931 |
| 98 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96774314 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96611581 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96009822 |
| 101 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95329499 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95047458 |
| 103 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94884458 |
| 104 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94863139 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94763267 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94584448 |
| 107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93969795 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93671917 |
| 109 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93466359 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92182170 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92080525 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91637459 |
| 113 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91550933 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91435387 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90936486 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90917364 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88727879 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88694029 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88004411 |
| 120 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87982743 |
| 121 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87058755 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86760745 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.86685883 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86674698 |
| 125 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86438094 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85787790 |
| 127 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.85741075 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84921998 |
| 129 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84912875 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84822280 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83726909 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83602924 |
| 133 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83536226 |
| 134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83294710 |
| 135 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83174400 |
| 136 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83110421 |
| 137 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83062678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 4.21536492 |
| 2 | MP0003195_calcinosis | 3.39620849 |
| 3 | MP0003950_abnormal_plasma_membrane | 2.83843949 |
| 4 | MP0005360_urolithiasis | 2.82186857 |
| 5 | MP0005332_abnormal_amino_acid | 2.79537607 |
| 6 | MP0009643_abnormal_urine_homeostasis | 2.77273123 |
| 7 | MP0004272_abnormal_basement_membrane | 2.66316863 |
| 8 | MP0001756_abnormal_urination | 2.64877306 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.60513264 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.60238769 |
| 11 | MP0006054_spinal_hemorrhage | 2.47235793 |
| 12 | MP0001958_emphysema | 2.42844796 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.37999014 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.31554560 |
| 15 | MP0003283_abnormal_digestive_organ | 2.31045349 |
| 16 | MP0002136_abnormal_kidney_physiology | 2.26231369 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.23936268 |
| 18 | MP0001765_abnormal_ion_homeostasis | 2.19704566 |
| 19 | MP0003252_abnormal_bile_duct | 2.14769575 |
| 20 | MP0000767_abnormal_smooth_muscle | 2.13452851 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.13408553 |
| 22 | MP0008961_abnormal_basal_metabolism | 2.12018055 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.05078026 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 2.03148851 |
| 25 | MP0001879_abnormal_lymphatic_vessel | 2.03133125 |
| 26 | MP0003828_pulmonary_edema | 1.95956724 |
| 27 | MP0003303_peritoneal_inflammation | 1.95265016 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.93815809 |
| 29 | MP0008004_abnormal_stomach_pH | 1.90279444 |
| 30 | MP0005670_abnormal_white_adipose | 1.89918418 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.85657647 |
| 32 | MP0000230_abnormal_systemic_arterial | 1.84689364 |
| 33 | MP0001661_extended_life_span | 1.83995606 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.78113427 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.78095823 |
| 36 | MP0001542_abnormal_bone_strength | 1.77010643 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.76897438 |
| 38 | MP0005275_abnormal_skin_tensile | 1.75010080 |
| 39 | MP0004233_abnormal_muscle_weight | 1.71972993 |
| 40 | MP0002928_abnormal_bile_duct | 1.64924126 |
| 41 | MP0003724_increased_susceptibility_to | 1.63197663 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.58060060 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.55553557 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.55369726 |
| 45 | MP0002168_other_aberrant_phenotype | 1.55194912 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.54945174 |
| 47 | MP0004883_abnormal_blood_vessel | 1.51545540 |
| 48 | MP0002135_abnormal_kidney_morphology | 1.47135068 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.41007510 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.40889537 |
| 51 | MP0004510_myositis | 1.39016298 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 1.38759075 |
| 53 | MP0000534_abnormal_ureter_morphology | 1.38382025 |
| 54 | MP0004484_altered_response_of | 1.36963819 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.36334056 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.34220174 |
| 57 | MP0002108_abnormal_muscle_morphology | 1.33715002 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.33690363 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.32700189 |
| 60 | MP0005365_abnormal_bile_salt | 1.32314800 |
| 61 | MP0005164_abnormal_response_to | 1.31024235 |
| 62 | MP0002090_abnormal_vision | 1.30308218 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.29581547 |
| 64 | MP0003941_abnormal_skin_development | 1.28887991 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.28541010 |
| 66 | MP0001270_distended_abdomen | 1.26064189 |
| 67 | MP0005023_abnormal_wound_healing | 1.22888754 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.22504811 |
| 69 | MP0003045_fibrosis | 1.21664830 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.19055935 |
| 71 | MP0003942_abnormal_urinary_system | 1.15807030 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.14794093 |
| 73 | MP0003279_aneurysm | 1.14333128 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.13545827 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.12751664 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.11164395 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.10447614 |
| 78 | MP0001944_abnormal_pancreas_morphology | 1.10261847 |
| 79 | MP0002933_joint_inflammation | 1.09851454 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.09790458 |
| 81 | MP0001299_abnormal_eye_distance/ | 1.09522864 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.06228194 |
| 83 | MP0003959_abnormal_lean_body | 1.05109196 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 1.02197516 |
| 85 | MP0001835_abnormal_antigen_presentation | 1.02102318 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.00619788 |
| 87 | MP0001790_abnormal_immune_system | 0.96958058 |
| 88 | MP0005387_immune_system_phenotype | 0.96958058 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.96807660 |
| 90 | MP0000249_abnormal_blood_vessel | 0.95990219 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.94231228 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.91879079 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.91766149 |
| 94 | MP0005165_increased_susceptibility_to | 0.90345358 |
| 95 | MP0000163_abnormal_cartilage_morphology | 0.89879228 |
| 96 | MP0001324_abnormal_eye_pigmentation | 0.88344818 |
| 97 | MP0005390_skeleton_phenotype | 0.87411299 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.86947785 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.86340693 |
| 100 | MP0002115_abnormal_skeleton_extremities | 0.85719915 |
| 101 | MP0000747_muscle_weakness | 0.85591282 |
| 102 | MP0005388_respiratory_system_phenotype | 0.85350435 |
| 103 | MP0002133_abnormal_respiratory_system | 0.85350435 |
| 104 | MP0000343_altered_response_to | 0.85147637 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.84438897 |
| 106 | MP0010030_abnormal_orbit_morphology | 0.83249393 |
| 107 | MP0005535_abnormal_body_temperature | 0.82970661 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.82748586 |
| 109 | MP0003868_abnormal_feces_composition | 0.82263097 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.82182921 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.81965684 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.81374300 |
| 113 | MP0002128_abnormal_blood_circulation | 0.80756929 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.80749687 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.79701220 |
| 116 | MP0000749_muscle_degeneration | 0.79679698 |
| 117 | MP0002127_abnormal_cardiovascular_syste | 0.79635191 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.78850041 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.77405796 |
| 120 | MP0005508_abnormal_skeleton_morphology | 0.77021258 |
| 121 | MP0003795_abnormal_bone_structure | 0.76709091 |
| 122 | MP0004130_abnormal_muscle_cell | 0.76558002 |
| 123 | MP0004087_abnormal_muscle_fiber | 0.76496348 |
| 124 | MP0003075_altered_response_to | 0.75074460 |
| 125 | MP0000733_abnormal_muscle_development | 0.74128009 |
| 126 | MP0005369_muscle_phenotype | 0.73640389 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.71440492 |
| 128 | MP0005000_abnormal_immune_tolerance | 0.70145777 |
| 129 | MP0001614_abnormal_blood_vessel | 0.69290789 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.67314517 |
| 131 | MP0003690_abnormal_glial_cell | 0.67232722 |
| 132 | MP0000751_myopathy | 0.67148461 |
| 133 | MP0003011_delayed_dark_adaptation | 0.66840323 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.65762033 |
| 135 | MP0002971_abnormal_brown_adipose | 0.65742116 |
| 136 | MP0005166_decreased_susceptibility_to | 0.65587426 |
| 137 | MP0002060_abnormal_skin_morphology | 0.65112480 |
| 138 | MP0005253_abnormal_eye_physiology | 0.64968061 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.63803944 |
| 140 | MP0001243_abnormal_dermal_layer | 0.63536604 |
| 141 | MP0000685_abnormal_immune_system | 0.63345870 |
| 142 | MP0001800_abnormal_humoral_immune | 0.63258068 |
| 143 | MP0005330_cardiomyopathy | 0.63193467 |
| 144 | MP0006082_CNS_inflammation | 0.62751110 |
| 145 | MP0006138_congestive_heart_failure | 0.62382165 |
| 146 | MP0002697_abnormal_eye_size | 0.59838504 |
| 147 | MP0003091_abnormal_cell_migration | 0.59625221 |
| 148 | MP0002269_muscular_atrophy | 0.58837010 |
| 149 | MP0000750_abnormal_muscle_regeneration | 0.57045491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.29779786 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 6.02416462 |
| 3 | Metabolic alkalosis (HP:0200114) | 5.58391696 |
| 4 | Hypomagnesemia (HP:0002917) | 5.35035673 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.33908264 |
| 6 | Protrusio acetabuli (HP:0003179) | 5.27953159 |
| 7 | Aortic dissection (HP:0002647) | 5.24539159 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.10306208 |
| 9 | Polyuria (HP:0000103) | 4.90991677 |
| 10 | Vascular tortuosity (HP:0004948) | 4.84674669 |
| 11 | Focal segmental glomerulosclerosis (HP:0000097) | 4.68188240 |
| 12 | Arterial tortuosity (HP:0005116) | 4.65561269 |
| 13 | Tetany (HP:0001281) | 4.58197683 |
| 14 | Abnormal urine output (HP:0012590) | 4.55546653 |
| 15 | Abnormality of magnesium homeostasis (HP:0004921) | 4.36281412 |
| 16 | Gout (HP:0001997) | 4.30890074 |
| 17 | Polydipsia (HP:0001959) | 4.26520447 |
| 18 | Abnormal drinking behavior (HP:0030082) | 4.26520447 |
| 19 | Abnormality of renal excretion (HP:0011036) | 4.20556309 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 4.11479560 |
| 21 | Glomerulosclerosis (HP:0000096) | 3.99719152 |
| 22 | Hypokalemia (HP:0002900) | 3.90035041 |
| 23 | Hyperaldosteronism (HP:0000859) | 3.74701211 |
| 24 | Mesangial abnormality (HP:0001966) | 3.63053875 |
| 25 | Alkalosis (HP:0001948) | 3.53216093 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 3.52714910 |
| 27 | Hematochezia (HP:0002573) | 3.49477182 |
| 28 | Spondylolisthesis (HP:0003302) | 3.44370116 |
| 29 | Ketoacidosis (HP:0001993) | 3.35385061 |
| 30 | Tubular atrophy (HP:0000092) | 3.33583279 |
| 31 | Soft skin (HP:0000977) | 3.30523367 |
| 32 | Abnormality of potassium homeostasis (HP:0011042) | 3.24354319 |
| 33 | Overgrowth (HP:0001548) | 3.13602494 |
| 34 | Proximal tubulopathy (HP:0000114) | 3.10678238 |
| 35 | Renal salt wasting (HP:0000127) | 3.08746084 |
| 36 | Round ear (HP:0100830) | 3.06826618 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 2.99200978 |
| 38 | Hydroxyprolinuria (HP:0003080) | 2.99200978 |
| 39 | Wrist flexion contracture (HP:0001239) | 2.98067076 |
| 40 | Increased purine levels (HP:0004368) | 2.97971130 |
| 41 | Hyperuricemia (HP:0002149) | 2.97971130 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.97535535 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.96427455 |
| 44 | Peritonitis (HP:0002586) | 2.96190736 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.95735917 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.95705256 |
| 47 | Hypophosphatemia (HP:0002148) | 2.91652379 |
| 48 | Hypercalciuria (HP:0002150) | 2.91538511 |
| 49 | Cervical subluxation (HP:0003308) | 2.87252477 |
| 50 | Stage 5 chronic kidney disease (HP:0003774) | 2.85599011 |
| 51 | Follicular hyperkeratosis (HP:0007502) | 2.85372167 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.83087287 |
| 53 | Striae distensae (HP:0001065) | 2.82683371 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 2.82551101 |
| 55 | Nephritis (HP:0000123) | 2.79487662 |
| 56 | Hypoalbuminemia (HP:0003073) | 2.78171703 |
| 57 | Abnormal albumin level (HP:0012116) | 2.78171703 |
| 58 | Lymphangioma (HP:0100764) | 2.77259745 |
| 59 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.76087975 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.68108273 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.66762753 |
| 62 | Nemaline bodies (HP:0003798) | 2.63162389 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.55401445 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.55387010 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54673503 |
| 66 | Genu recurvatum (HP:0002816) | 2.54124035 |
| 67 | Facial shape deformation (HP:0011334) | 2.50655705 |
| 68 | Potter facies (HP:0002009) | 2.50655705 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.43990014 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.41959004 |
| 71 | Glomerulonephritis (HP:0000099) | 2.41949580 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.41823076 |
| 73 | Ketosis (HP:0001946) | 2.41597647 |
| 74 | Nephrocalcinosis (HP:0000121) | 2.40883217 |
| 75 | Emphysema (HP:0002097) | 2.39856214 |
| 76 | Atrophic scars (HP:0001075) | 2.39060614 |
| 77 | Hyperglycinuria (HP:0003108) | 2.35789457 |
| 78 | Blue sclerae (HP:0000592) | 2.33716321 |
| 79 | Spinal rigidity (HP:0003306) | 2.33298202 |
| 80 | Wormian bones (HP:0002645) | 2.28498642 |
| 81 | Hypoglycemic coma (HP:0001325) | 2.27501314 |
| 82 | Distal arthrogryposis (HP:0005684) | 2.26491425 |
| 83 | Aneurysm (HP:0002617) | 2.26181736 |
| 84 | Muscle fiber inclusion bodies (HP:0100299) | 2.24374252 |
| 85 | Ankle contracture (HP:0006466) | 2.24031033 |
| 86 | Renal tubular acidosis (HP:0001947) | 2.22950678 |
| 87 | Aortic valve stenosis (HP:0001650) | 2.21518432 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.20906789 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.20799231 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20799231 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.20036669 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.19988457 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.19076027 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.18117676 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17812432 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17812432 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17812432 |
| 98 | Adrenal overactivity (HP:0002717) | 2.17688749 |
| 99 | Bladder diverticulum (HP:0000015) | 2.16217639 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.10311213 |
| 101 | Broad metatarsal (HP:0001783) | 2.09372960 |
| 102 | Decreased circulating renin level (HP:0003351) | 2.09281114 |
| 103 | Chondrocalcinosis (HP:0000934) | 2.08651451 |
| 104 | Fragile skin (HP:0001030) | 2.06482752 |
| 105 | Slender build (HP:0001533) | 2.06402391 |
| 106 | Aortic aneurysm (HP:0004942) | 2.05668315 |
| 107 | Enlarged kidneys (HP:0000105) | 2.05106551 |
| 108 | Hypoplasia of the iris (HP:0007676) | 2.04807164 |
| 109 | Flexion contracture of toe (HP:0005830) | 2.04474237 |
| 110 | Joint contractures involving the joints of the feet (HP:0100492) | 2.04474237 |
| 111 | Central scotoma (HP:0000603) | 2.03603041 |
| 112 | Retinal atrophy (HP:0001105) | 2.03468173 |
| 113 | Camptodactyly of toe (HP:0001836) | 2.03232957 |
| 114 | Abnormality of Sharpey fibers (HP:0100685) | 2.01981383 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 2.01092520 |
| 116 | Limited hip movement (HP:0008800) | 2.00522146 |
| 117 | Joint laxity (HP:0001388) | 2.00065516 |
| 118 | Abnormality of dentin (HP:0010299) | 1.98505189 |
| 119 | Hyperextensible skin (HP:0000974) | 1.97506671 |
| 120 | Mesomelia (HP:0003027) | 1.97254751 |
| 121 | Neonatal short-limb short stature (HP:0008921) | 1.96419285 |
| 122 | Generalized muscle weakness (HP:0003324) | 1.95995217 |
| 123 | Thin bony cortex (HP:0002753) | 1.95504751 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.94494645 |
| 125 | Glycosuria (HP:0003076) | 1.94494645 |
| 126 | Cardiovascular calcification (HP:0011915) | 1.94335351 |
| 127 | Ulnar deviation of the wrist (HP:0003049) | 1.92948493 |
| 128 | Hypoplastic ischia (HP:0003175) | 1.92481919 |
| 129 | Delayed epiphyseal ossification (HP:0002663) | 1.91858477 |
| 130 | Bundle branch block (HP:0011710) | 1.90463314 |
| 131 | Premature rupture of membranes (HP:0001788) | 1.88917841 |
| 132 | Tubulointerstitial abnormality (HP:0001969) | 1.87640494 |
| 133 | Hypoglycemic seizures (HP:0002173) | 1.87254219 |
| 134 | Osteolytic defects of the hand bones (HP:0009699) | 1.87157381 |
| 135 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87157381 |
| 136 | Aortic regurgitation (HP:0001659) | 1.87028722 |
| 137 | Cerebral aneurysm (HP:0004944) | 1.86652126 |
| 138 | Symptomatic seizures (HP:0011145) | 1.85670595 |
| 139 | Polycythemia (HP:0001901) | 1.85605665 |
| 140 | Bradycardia (HP:0001662) | 1.84913065 |
| 141 | Abnormal urine phosphate concentration (HP:0012599) | 1.84631169 |
| 142 | Metaphyseal dysplasia (HP:0100255) | 1.83564163 |
| 143 | Glucose intolerance (HP:0000833) | 1.83526382 |
| 144 | Abnormality of the ischium (HP:0003174) | 1.83281239 |
| 145 | Vascular calcification (HP:0004934) | 1.82052751 |
| 146 | Progressive visual loss (HP:0000529) | 1.81824490 |
| 147 | Abnormal tarsal ossification (HP:0008369) | 1.81166397 |
| 148 | Cellulitis (HP:0100658) | 1.81081104 |
| 149 | Nephrotic syndrome (HP:0000100) | 1.80929461 |
| 150 | Mild short stature (HP:0003502) | 1.79925437 |
| 151 | Joint stiffness (HP:0001387) | 1.77805246 |
| 152 | Difficulty running (HP:0009046) | 1.76852568 |
| 153 | Hyperphosphaturia (HP:0003109) | 1.76749652 |
| 154 | Muscle fiber splitting (HP:0003555) | 1.76436228 |
| 155 | Thoracolumbar scoliosis (HP:0002944) | 1.74955858 |
| 156 | Abnormality of the calf musculature (HP:0001430) | 1.74558052 |
| 157 | Hip contracture (HP:0003273) | 1.74350294 |
| 158 | Hypoplasia of the odontoid process (HP:0003311) | 1.74040744 |
| 159 | Nephrolithiasis (HP:0000787) | 1.74030580 |
| 160 | Mitral stenosis (HP:0001718) | 1.73869260 |
| 161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.72917336 |
| 162 | Hyperkalemia (HP:0002153) | 1.72331452 |
| 163 | Absent frontal sinuses (HP:0002688) | 1.70510432 |
| 164 | Long toe (HP:0010511) | 1.69770874 |
| 165 | Papilledema (HP:0001085) | 1.69345747 |
| 166 | Abnormality of macular pigmentation (HP:0008002) | 1.69210859 |
| 167 | Recurrent bronchitis (HP:0002837) | 1.69059102 |
| 168 | Ectopia lentis (HP:0001083) | 1.68608937 |
| 169 | Conjunctival telangiectasia (HP:0000524) | 1.68238442 |
| 170 | Proteinuria (HP:0000093) | 1.68189957 |
| 171 | Abnormal pancreas size (HP:0012094) | 1.67676309 |
| 172 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67615652 |
| 173 | Popliteal pterygium (HP:0009756) | 1.67548426 |
| 174 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.66790160 |
| 175 | Abnormality of glycine metabolism (HP:0010895) | 1.66790160 |
| 176 | Pigmentary retinal degeneration (HP:0001146) | 1.66757459 |
| 177 | Increased connective tissue (HP:0009025) | 1.66628714 |
| 178 | Mucosal telangiectasiae (HP:0100579) | 1.64775858 |
| 179 | Bell-shaped thorax (HP:0001591) | 1.64653731 |
| 180 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.60759583 |
| 181 | Knee flexion contracture (HP:0006380) | 1.59332764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 6.71292418 |
| 2 | WNK3 | 5.21641604 |
| 3 | OXSR1 | 4.46897826 |
| 4 | STK39 | 2.90656824 |
| 5 | INSRR | 2.89543398 |
| 6 | MAP3K12 | 2.89332633 |
| 7 | BLK | 2.15802721 |
| 8 | RIPK4 | 2.11950624 |
| 9 | TGFBR2 | 2.09725519 |
| 10 | BMPR2 | 2.07015502 |
| 11 | EPHB2 | 1.88819617 |
| 12 | FRK | 1.88467429 |
| 13 | SIK1 | 1.80966584 |
| 14 | STK38L | 1.72627829 |
| 15 | EPHA3 | 1.69401059 |
| 16 | WNK1 | 1.69357304 |
| 17 | MUSK | 1.62970046 |
| 18 | ERN1 | 1.59567327 |
| 19 | LIMK1 | 1.56608725 |
| 20 | PDGFRA | 1.54147531 |
| 21 | BCKDK | 1.50413804 |
| 22 | PTK2B | 1.47226332 |
| 23 | LATS1 | 1.47005189 |
| 24 | MYLK | 1.45759296 |
| 25 | MOS | 1.42877799 |
| 26 | TRIB3 | 1.36485091 |
| 27 | CAMK1D | 1.33796714 |
| 28 | SGK223 | 1.29991097 |
| 29 | SGK494 | 1.29991097 |
| 30 | FGFR4 | 1.24080665 |
| 31 | SGK2 | 1.23882254 |
| 32 | FER | 1.20599380 |
| 33 | GRK7 | 1.18307151 |
| 34 | CAMK1G | 1.17272087 |
| 35 | TIE1 | 1.16943621 |
| 36 | PTK6 | 1.14782805 |
| 37 | SGK3 | 1.13817800 |
| 38 | MAP3K3 | 1.10817476 |
| 39 | RIPK1 | 1.06099410 |
| 40 | NTRK3 | 1.06052864 |
| 41 | MAP2K3 | 1.05526734 |
| 42 | TTN | 1.03833640 |
| 43 | IRAK3 | 1.03745997 |
| 44 | PRKD3 | 1.03570307 |
| 45 | JAK1 | 1.03061136 |
| 46 | NTRK1 | 1.02703316 |
| 47 | TEC | 0.99961981 |
| 48 | IRAK2 | 0.99911867 |
| 49 | PRKCH | 0.95519915 |
| 50 | PAK3 | 0.95460710 |
| 51 | GRK1 | 0.94478077 |
| 52 | PIK3CG | 0.93988127 |
| 53 | CSK | 0.93744832 |
| 54 | PAK6 | 0.93607342 |
| 55 | MAP3K2 | 0.89494857 |
| 56 | PLK2 | 0.87727003 |
| 57 | IRAK1 | 0.87234645 |
| 58 | ROCK2 | 0.86677857 |
| 59 | PTK2 | 0.86571884 |
| 60 | TAOK3 | 0.86462754 |
| 61 | SIK3 | 0.85005919 |
| 62 | MAPK7 | 0.84265093 |
| 63 | PAK4 | 0.84052652 |
| 64 | PRKAA1 | 0.82322189 |
| 65 | FES | 0.82215357 |
| 66 | MAP3K14 | 0.81076020 |
| 67 | PDK2 | 0.80817730 |
| 68 | NEK9 | 0.80199161 |
| 69 | JAK3 | 0.79948924 |
| 70 | * ROCK1 | 0.79481947 |
| 71 | MARK2 | 0.79187683 |
| 72 | MAP3K7 | 0.77326425 |
| 73 | IRAK4 | 0.76874034 |
| 74 | DYRK1B | 0.76205101 |
| 75 | PRKD2 | 0.74554545 |
| 76 | SYK | 0.73930261 |
| 77 | EPHB1 | 0.72740877 |
| 78 | MAPK15 | 0.72202363 |
| 79 | HCK | 0.72190998 |
| 80 | STK38 | 0.67776639 |
| 81 | CSF1R | 0.67540904 |
| 82 | PRKAA2 | 0.67256047 |
| 83 | GSK3A | 0.66136702 |
| 84 | PDK1 | 0.65711472 |
| 85 | HIPK2 | 0.65048080 |
| 86 | TESK1 | 0.64925680 |
| 87 | NLK | 0.64484171 |
| 88 | PDK4 | 0.63351620 |
| 89 | PDK3 | 0.63351620 |
| 90 | MAP3K13 | 0.61646365 |
| 91 | TYK2 | 0.60909254 |
| 92 | ZAP70 | 0.60743341 |
| 93 | BTK | 0.59907298 |
| 94 | PRKCE | 0.59718487 |
| 95 | SGK1 | 0.58999975 |
| 96 | OBSCN | 0.56786317 |
| 97 | PDGFRB | 0.56205817 |
| 98 | MAP3K6 | 0.54004630 |
| 99 | ABL1 | 0.52318559 |
| 100 | ERBB3 | 0.52244481 |
| 101 | IKBKE | 0.52126179 |
| 102 | DDR2 | 0.51952275 |
| 103 | GRK5 | 0.50681884 |
| 104 | MST1R | 0.50263966 |
| 105 | FGFR3 | 0.50152598 |
| 106 | PINK1 | 0.49539147 |
| 107 | CDC42BPA | 0.49140493 |
| 108 | AKT3 | 0.47942440 |
| 109 | PHKG1 | 0.47581183 |
| 110 | PHKG2 | 0.47581183 |
| 111 | DMPK | 0.46799063 |
| 112 | MAP4K1 | 0.46574901 |
| 113 | TBK1 | 0.46440180 |
| 114 | FGFR2 | 0.44164542 |
| 115 | MAP2K1 | 0.43921967 |
| 116 | MAP3K5 | 0.43561778 |
| 117 | SIK2 | 0.43092529 |
| 118 | CHUK | 0.41811431 |
| 119 | ADRBK1 | 0.40998803 |
| 120 | KIT | 0.39974330 |
| 121 | IGF1R | 0.39118529 |
| 122 | MTOR | 0.38766468 |
| 123 | STK10 | 0.38078435 |
| 124 | JAK2 | 0.37692261 |
| 125 | PRKG2 | 0.35660882 |
| 126 | DAPK2 | 0.35432937 |
| 127 | PRKD1 | 0.33573958 |
| 128 | MET | 0.32885311 |
| 129 | TRPM7 | 0.31896713 |
| 130 | PRKACG | 0.31832066 |
| 131 | CAMKK2 | 0.31756250 |
| 132 | SRC | 0.28239365 |
| 133 | INSR | 0.27662862 |
| 134 | MAPK12 | 0.26425883 |
| 135 | MAP3K1 | 0.26144577 |
| 136 | RPS6KA2 | 0.25652251 |
| 137 | MARK3 | 0.24738007 |
| 138 | STK3 | 0.23895572 |
| 139 | PAK2 | 0.23427985 |
| 140 | PDPK1 | 0.23412860 |
| 141 | PIK3CA | 0.23110495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44304835 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37945125 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.33412210 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.29000127 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15156229 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.11811015 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09241088 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.04112564 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85673228 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.84832790 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68731131 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67279498 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63517560 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.62481544 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61245264 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59761335 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58888842 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57531885 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56424743 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56189429 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54524733 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.52163850 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.45737565 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.42812792 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.41042668 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40745681 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.40569806 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40048251 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39303924 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38114981 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37849579 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35480280 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33638759 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.24354763 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24297467 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.23909819 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23696265 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.20660698 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20529170 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20460476 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19383018 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18583600 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18296734 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.16077865 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.15623714 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.12214096 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.12190785 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11963913 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11239653 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09898464 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.09390122 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09323644 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07002443 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05615445 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05491136 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.04576625 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 1.04025905 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03182114 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 1.02943091 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.02550494 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99453763 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.99116630 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97883349 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.95673744 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94247003 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94022997 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93052175 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92304430 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89947721 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89615050 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.88880375 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88740747 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88035686 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87459452 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84700081 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81375640 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80735311 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80683879 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80021167 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78404053 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78205378 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77942619 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76777547 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76400619 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76172912 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75770580 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75132797 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73405873 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72982757 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72763505 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72124826 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71806730 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.70858885 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70259490 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.70059424 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70043394 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69842376 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.69430182 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.69397049 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.68844456 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68593595 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67164915 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66530407 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65977913 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65522030 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65463475 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65411238 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65068441 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64867583 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63621111 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.63594127 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61842535 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61210816 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60733099 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60250330 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59742029 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59295103 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59210440 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.58790035 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.58329858 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57253604 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57102195 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53835862 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53609045 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53553852 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53324839 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.53311671 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53064541 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.52737498 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52482932 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52458212 |
| 132 | Long-term depression_Homo sapiens_hsa04730 | 0.51939235 |
| 133 | Hepatitis B_Homo sapiens_hsa05161 | 0.51871220 |
| 134 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51868902 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51839073 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48212380 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45236136 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43920261 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.43688914 |
| 140 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43498094 |
| 141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40586915 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39212879 |
| 143 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38898162 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38607858 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.38538986 |
| 146 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38161033 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37796533 |
| 148 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35935491 |
| 149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35351487 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32776369 |
| 151 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32108165 |
| 152 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31461518 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31351949 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30831481 |
| 155 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30474134 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28365470 |
| 157 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27605724 |
| 158 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27320390 |
| 159 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27149250 |
| 160 | Adherens junction_Homo sapiens_hsa04520 | 0.27119070 |
| 161 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25937716 |
| 162 | Prostate cancer_Homo sapiens_hsa05215 | 0.25197779 |

